A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers

NCT04994106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: AZD5462
DRUG: Placebo

Sponsor

AstraZeneca